Metraipolis › archive › dc_c0d767a9732d
Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation — Europe PMC PMID:41374990
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41374990
- DOI
- 10.3390/cancers17233788
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:58:18.062Z
- SHA-256 of the archived text
2674bacd0d24335506a8f3dae1ce3d6a5ba5579b5376990c53c5fcbc0e26dd73- Stable URL of this page
https://metraipolis.com/documento/dc_c0d767a9732d
How to cite
Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation — Europe PMC PMID:41374990 — Europe PMC (en), https://europepmc.org/article/MED/41374990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c0d767a9732d (Metraipolis archive dc_c0d767a9732d, sha256 2674bacd0d24335506a8f3dae1ce3d6a5ba5579b5376990c53c5fcbc0e26dd73)
BibTeX
@misc{dcc0d767a9732d,
title = {Neurofibromatosis Type 1: Genetic Mechanisms and Advances in Therapeutic Innovation — Europe PMC PMID:41374990},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41374990},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c0d767a9732d; sha256 2674bacd0d24335506a8f3dae1ce3d6a5ba5579b5376990c53c5fcbc0e26dd73},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374990. Agents can read the archived copy with the MCP tool read_document.